ST Pharm Co.,Ltd. (KOSDAQ:237690)

ST Pharm Revenue

ST Pharm had revenue of 108.48B KRW in the quarter ending June 30, 2026, with 58.95% growth. This brings the company's total for the last twelve months to 386.46B, up 29.64% year-over-year. In the year 2025, ST Pharm had annual revenue of 331.68B with 21.16% growth. That makes ST Pharm the 14,720th largest company in the world by revenue and 730th in South Korea.

• Revenue (ttm): 386.46B
• Revenue Growth: +29.64%
• P/S Ratio: 4.78
• Revenue / Employee: 590.01M
• Employees: 655
• Market Cap: 1.85T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Raw Material Manufacturing 293.18B 86.7%
• Clinical Trial Contract Research 44.94B 13.3%

By Geography

Chart

• USA 122.43B 36.9%
• Switzerland 104.46B 31.5%
• Other Countries 74.80B 22.6%
• Korea 29.99B 9.0%

Fiscal year ended Dec 31, 2025 See the full ST Pharm breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	331.68B	57.93B	21.16%
Dec 31, 2024	273.75B	-11.24B	-3.94%
Dec 31, 2023	284.99B	35.67B	14.31%
Dec 31, 2022	249.32B	83.68B	50.52%
Dec 31, 2021	165.64B	41.53B	33.47%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error